Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527754) titled 'S100B Protein: a Diagnostic Aid in Episodes of Transient Loss of Consciousness?' on April 7.

Study Type: Observational

Primary Sponsor: Assistance Publique - Hopitaux de Paris

Condition: Epilepsy Cryptogenic Epilepsy

Recruitment Status: Not recruiting

Date of First Enrollment: April 30, 2026

Target Sample Size: 100

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07527754

Published by HT Digital Content Services with permission from Health Daily Digest....